Dec 05, 2019 / 03:30PM GMT
William Robert Quirk - Piper Jaffray Companies, Research Division - MD and Senior Research Analyst
All right. Thanks. Good morning, everyone. Welcome to the 10:30 session. I'm Bill Quirk, the Tools and Diagnostics Analyst here at Piper Jaffray. And I have the pleasure of welcoming to the podium the Chief Financial Officer from Illumina, Sam Samad. Sam has some opening comments, and then we will get right into Q&A. Sam?
Sam A. Samad - Illumina, Inc. - CFO & Senior VP
Yes. Thank you, Bill. So I would like to start with the safe harbor, and then we can go straight to Q&A, if that's okay.
So I've been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It is our intent that all forward-looking statements regarding our financial results and commercial activity made during today's discussion will be protected under the Private Securities Litigation Reform
Illumina Inc at Piper Jaffray Healthcare Conference Transcript
Dec 05, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers